208 related articles for article (PubMed ID: 34302511)
1. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt.
Lu HL; Xuan FF; Luo YC; Qin X
Abdom Radiol (NY); 2021 Nov; 46(11):5417-5427. PubMed ID: 34302511
[TBL] [Abstract][Full Text] [Related]
2. Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.
Zou X; Xue M; Li J
Med Sci Monit; 2021 Nov; 27():e934436. PubMed ID: 34840325
[TBL] [Abstract][Full Text] [Related]
3. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
4. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma.
Balducci D; Montori M; De Blasio F; Di Bucchianico A; Argenziano ME; Baroni GS; Scarpellini E
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374354
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
6. Prevention of variceal rebleeding and treatment of liver carcinoma by consecutive transjugular intrahepatic portosystemic shunt and hepatic artery chemoembolization.
Nicolini A; Saccheri S; Lovaria A; Maggi A; Cazzaniga M; Panzeri A; Salerno F
Ital J Gastroenterol; 1996 Jun; 28(5):269-71. PubMed ID: 8842845
[TBL] [Abstract][Full Text] [Related]
7. Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
Chen X; Qiu ZK; Wang GB; Chen XL; Zhang FJ; Gao F
Diagn Interv Radiol; 2021 Sep; 27(5):671-676. PubMed ID: 34318755
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review.
Norero B; Bosch J; Berzigotti A; Rodrigues SG
United European Gastroenterol J; 2023 Oct; 11(8):733-744. PubMed ID: 37736854
[TBL] [Abstract][Full Text] [Related]
9. Trans-jugular intrahepatic portosystemic shunt in patients with hepatic cellular carcinoma: A preliminary study.
Dong H; Zhang C; Li Z; Yang H; Wang Y; Liu J; Liu B; Mao S
J Cancer Res Ther; 2021 Jul; 17(3):784-789. PubMed ID: 34269314
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma.
Luo SH; Chu JG; Huang H; Yao KC
World J Clin Cases; 2019 Jul; 7(13):1599-1610. PubMed ID: 31367619
[TBL] [Abstract][Full Text] [Related]
12. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Qiu B; Li K; Dong X; Liu FQ
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
14. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.
Zhao JB; Feng C; Zhu QH; He XF; Li YH; Chen Y
World J Gastroenterol; 2014 Feb; 20(6):1602-7. PubMed ID: 24587637
[TBL] [Abstract][Full Text] [Related]
16. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
Wei J; Li H; Li C
J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
[TBL] [Abstract][Full Text] [Related]
19. Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report.
Sakaguchi H; Uchida H; Maeda M; Matsuo N; Kichikawa K; Ohishi H; Nishida H; Ueno K; Nishimine K; Rösch J
Cardiovasc Intervent Radiol; 1995; 18(1):9-15. PubMed ID: 7540504
[TBL] [Abstract][Full Text] [Related]
20. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
